Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
NCT05541250

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

Led by W. Dalton Dietrich · Updated on 2025-09-02

30

Participants Needed

1

Research Sites

177 weeks

Total Duration

On this page

Sponsors

W

W. Dalton Dietrich

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

The primary purpose of this research study is to evaluate the safety and possible harms of injecting one's own Schwann cells along with nerve auto-graft after a severe injury to a major nerve has occurred.

CONDITIONS

Official Title

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Persons with severe sciatic nerve injury, brachial plexus injury, and/or major nerve injury at the upper or lower extremity within previous year
  • Between the ages of 18 and 65 at last birthday
Not Eligible

You will not qualify if you...

  • Persons unable to safely undergo an MRI
  • Persons with pre-existing conditions that would preclude satisfactory sural nerve harvest
  • Persons with severe peripheral nerve injury gap length > 10 cm
  • Persons with history of radiation or local cancer in area of nerve injury, including primary tumors of the nerve
  • Pregnant women or a positive pregnancy test in those women with reproductive potential prior to enrollment
  • Presence of disease that might interfere with participant safety, compliance, or evaluation of the condition under study
  • History of active substance abuse
  • Persons allergic to gentamicin
  • Persons who test positive for HIV or Hepatitis B or C virus
  • Persons unable to provide consent independently due to cognitive impairment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Miami

Miami, Florida, United States, 33136

Actively Recruiting

Loading map...

Research Team

G

George Jimsheleishvilli, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI) | DecenTrialz